For the quarter ending 2026-03-31, ACHV has $33,105K in assets. $22,427K in debts. $28,078K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid expenses and other assets | - | - | 1,941 | 1,506 |
| Cash and cash equivalents note 5 | 28,078 | 20,929 | 31,930 | 51,874 |
| Marketable securities note 5 | 1,191 | 15,475 | 16,184 | 3,523 |
| Prepaid expenses and other assets-Nonrelated Party | 1,667 | 3,292 | - | - |
| Prepaid expenses and other assets-Related Party | 125 | 193 | - | - |
| Total current assets | 31,061 | 39,889 | 50,055 | 56,903 |
| Restricted cash and other assets note 6 and note 7 | - | 52 | - | - |
| Other assets and restricted cash note 5 | 265 | - | 65 | 42 |
| Right-of-use assets note 9 | 49 | 64 | 79 | 93 |
| License agreement note 3 and note 4 | 696 | 751 | 807 | 863 |
| Goodwill | 1,034 | 1,034 | 1,034 | 1,034 |
| Total assets | 33,105 | 41,790 | 52,040 | 58,935 |
| Accounts payable-Nonrelated Party | 806 | 859 | - | - |
| Accounts payable-Related Party | 27 | 8 | - | - |
| Accrued liabilities other-Nonrelated Party | 2,332 | 598 | - | - |
| Accounts payable | - | - | 1,943 | 1,218 |
| Accrued liabilities other-Related Party | 5 | 6 | - | - |
| Accrued liabilities other | - | - | 1,802 | 1,219 |
| Accrued clinical liabilities-Nonrelated Party | 635 | - | - | - |
| Accrued clinical liabilities | - | 368 | 850 | 1,970 |
| Accrued clinical liabilities-Related Party | 216 | - | - | - |
| Accrued compensation | 2,182 | 1,921 | 2,429 | 1,563 |
| Current contingent consideration note 4 and note 5 | 0 | 1,557 | 1,443 | 1,337 |
| Current portion of long-term obligations note 9 | 51 | 61 | 59 | 58 |
| Current portion of convertible debt note 5 and note 6 | 5,579 | 3,704 | 1,204 | 1,208 |
| Total current liabilities | 11,833 | 9,082 | 9,730 | 8,573 |
| Long-term obligations note 12 | - | 5 | 21 | 37 |
| Non-current portion of convertible debt note 5 and note 6 | 9,322 | 11,185 | 8,674 | 8,657 |
| Convertible preferred stock, value-Series BConvertible Preferred Stock | - | - | - | 0 |
| Non-current contingent consideration note 4 and note 5 | 1,272 | 0 | 0 | 0 |
| Convertible preferred stock, value-Series AConvertible Preferred Stock | - | - | - | 0 |
| Total liabilities | 22,427 | 20,272 | 18,425 | 17,267 |
| Common stock, 0.001 par value, 150,000,000 shares authorized, 53,240,988 issued and outstanding at march 31, 2026 and 53,233,988 issued and outstanding at december 31, 2025 | 121 | 121 | 121 | 118 |
| Additional paid-in capital | 280,949 | 281,613 | 279,049 | 272,670 |
| Accumulated deficit | -270,394 | -260,226 | -245,564 | -231,123 |
| Accumulated other comprehensive income | 2 | 10 | 9 | 3 |
| Total stockholders' equity | 10,678 | 21,518 | 33,615 | 41,668 |
| Total liabilities and stockholders' equity | 33,105 | 41,790 | 52,040 | 58,935 |
ACHIEVE LIFE SCIENCES, INC. (ACHV)
ACHIEVE LIFE SCIENCES, INC. (ACHV)